hssssssl
01-26
发生了什么事 谁知道
药明系个股午后全线闪崩!药明生物CEO陈智胜回应市场传闻
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
LukeMaya
01-26
LukeMaya
[微笑]
hssssssl
:
还是要有核心竞争力那 光搞 CXO没出路
hssssssl
:
哎呦 老美又搞事情
什么也没有了~
APP内打开
发表看法
3
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":267226112983112,"tweetId":"267226112983112","gmtCreate":1706250230178,"gmtModify":1706250231632,"author":{"id":3566808741894846,"authorId":3566808741894846,"authorIdStr":"3566808741894846","name":"hssssssl","avatar":"https://static.tigerbbs.com/292e62bc391ddf29d9637dac9cd1ada8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","exceedPercentage":"80.07%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>发生了什么事 谁知道</p></body></html>","htmlText":"<html><head></head><body><p>发生了什么事 谁知道</p></body></html>","text":"发生了什么事 谁知道","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/267226112983112","repostId":1112338489,"repostType":2,"repost":{"id":"1112338489","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1706249473,"share":"https://www.laohu8.com/m/news/1112338489?lang=&edition=full","pubTime":"2024-01-26 14:11","market":"hk","language":"zh","title":"药明系个股午后全线闪崩!药明生物CEO陈智胜回应市场传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=1112338489","media":"老虎资讯综合","summary":"1月26日,药明系个股午后大幅跳水,A股$药明康德(603259)$跌停,H股$药明康德(02359)$跌超20%,H股$药明生物(02269)$跌超16%,H股$药明合联(02268)$跌超12%。","content":"<html><head></head><body><p>1月26日,药明系个股午后大幅跳水,A股<a href=\"https://laohu8.com/S/603259\">药明康德</a>跌停,H股<a href=\"https://laohu8.com/S/02359\">药明康德</a>跌超20%,H股<a href=\"https://laohu8.com/S/02269\">药明生物</a>跌超16%,H股<a href=\"https://laohu8.com/S/02268\">药明合联</a>跌超12%。</p><p>消息面:市场流传美国拟出台《生物安全法案》,确保外国生物技术公司无法获得美国纳税人的资金,其中提及的公司有华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国公司药明康德。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2bf0a48c0becec719d431855aa16ab11\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27ec464c8126243374cd8cbd9534c820\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p>美国与中国战略竞争众议院特别委员会主席迈克·加拉格尔(R-WI)和高级成员拉贾·克里希纳莫蒂(D-IL)今天提出了一项法案,以确保外国生物技术公司无法获得美国纳税人的资金。</p><p style=\"text-align: justify;\">一旦颁布,该立法将限制联邦资助的医疗服务提供者使用外国对手生物技术公司,包括华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国-公司药明康德。</p><p style=\"text-align: justify;\">罗姆尼参议员表示:“中国的生物技术公司正在通过医疗诊断测试收集世界各地数百万人的基因和敏感健康数据。”“我们的两党立法禁止与中国有联系的公司签订联邦合同和融资机制,这有助于确保美国纳税人的钱不被用来补贴威胁我们国家安全的生物技术公司。”</p><p style=\"text-align: justify;\">“每天,美国人都会抽血或接受其他医学检查以保护他们的健康。但是,很少有人确切知道谁有权访问这些样本中包含的DNA信息,或者他们会如何使用这些信息。从DNA检测试剂盒到医疗诊断,随着生物技术领域在日常生活中变得越来越重要,外国对手控制的生物技术公司构成的威胁持续增长。”“这项法案将保护美国人的个人健康和遗传信息免受外国对手的侵害,这些对手有能力和动机利用这些信息来破坏我们的国家安全。”</p><p style=\"text-align: justify;\">不过,这份提案是否最终能够通过,还有待观察。此前,涉外的医药公司亦遭遇过多次黑天鹅事件,但随后均一一化解。这次,是否能够避免冲击,或许还需要有关方面更进一步的解释。</p><p style=\"text-align: justify;\">针对美国个别议员拟相关生物安全法提案提议禁止华大基因、药明康德等外国生物公司一事,以及文件中提及“药明生物首席执行官陈智胜曾任中国人民解放军军事医学科学院兼职教授”这一信息,1月26日下午,药明生物首席执行官陈智胜在回应界面新闻记者时称,“这只是一个反华议员的提议,到变成法律是极小概率事件,而且要几年时间。我个人也没有在军方任何机构任职过。我们会尽快公告澄清一下。”</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明系个股午后全线闪崩!药明生物CEO陈智胜回应市场传闻</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明系个股午后全线闪崩!药明生物CEO陈智胜回应市场传闻\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-01-26 14:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>1月26日,药明系个股午后大幅跳水,A股<a href=\"https://laohu8.com/S/603259\">药明康德</a>跌停,H股<a href=\"https://laohu8.com/S/02359\">药明康德</a>跌超20%,H股<a href=\"https://laohu8.com/S/02269\">药明生物</a>跌超16%,H股<a href=\"https://laohu8.com/S/02268\">药明合联</a>跌超12%。</p><p>消息面:市场流传美国拟出台《生物安全法案》,确保外国生物技术公司无法获得美国纳税人的资金,其中提及的公司有华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国公司药明康德。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2bf0a48c0becec719d431855aa16ab11\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27ec464c8126243374cd8cbd9534c820\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p>美国与中国战略竞争众议院特别委员会主席迈克·加拉格尔(R-WI)和高级成员拉贾·克里希纳莫蒂(D-IL)今天提出了一项法案,以确保外国生物技术公司无法获得美国纳税人的资金。</p><p style=\"text-align: justify;\">一旦颁布,该立法将限制联邦资助的医疗服务提供者使用外国对手生物技术公司,包括华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国-公司药明康德。</p><p style=\"text-align: justify;\">罗姆尼参议员表示:“中国的生物技术公司正在通过医疗诊断测试收集世界各地数百万人的基因和敏感健康数据。”“我们的两党立法禁止与中国有联系的公司签订联邦合同和融资机制,这有助于确保美国纳税人的钱不被用来补贴威胁我们国家安全的生物技术公司。”</p><p style=\"text-align: justify;\">“每天,美国人都会抽血或接受其他医学检查以保护他们的健康。但是,很少有人确切知道谁有权访问这些样本中包含的DNA信息,或者他们会如何使用这些信息。从DNA检测试剂盒到医疗诊断,随着生物技术领域在日常生活中变得越来越重要,外国对手控制的生物技术公司构成的威胁持续增长。”“这项法案将保护美国人的个人健康和遗传信息免受外国对手的侵害,这些对手有能力和动机利用这些信息来破坏我们的国家安全。”</p><p style=\"text-align: justify;\">不过,这份提案是否最终能够通过,还有待观察。此前,涉外的医药公司亦遭遇过多次黑天鹅事件,但随后均一一化解。这次,是否能够避免冲击,或许还需要有关方面更进一步的解释。</p><p style=\"text-align: justify;\">针对美国个别议员拟相关生物安全法提案提议禁止华大基因、药明康德等外国生物公司一事,以及文件中提及“药明生物首席执行官陈智胜曾任中国人民解放军军事医学科学院兼职教授”这一信息,1月26日下午,药明生物首席执行官陈智胜在回应界面新闻记者时称,“这只是一个反华议员的提议,到变成法律是极小概率事件,而且要几年时间。我个人也没有在军方任何机构任职过。我们会尽快公告澄清一下。”</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","relate_stocks":{"603259":"药明康德","02359":"药明康德","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","02268":"药明合联","BK1583":"高瓴概念","LU0052750758.USD":"富兰克林中国基金A Acc","BK0216":"研究试验","02269":"药明生物","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1141":"生命科学工具和服务","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1997245177.USD":"安联神洲A股基金","BK1576":"医药外包概念"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112338489","content_text":"1月26日,药明系个股午后大幅跳水,A股药明康德跌停,H股药明康德跌超20%,H股药明生物跌超16%,H股药明合联跌超12%。消息面:市场流传美国拟出台《生物安全法案》,确保外国生物技术公司无法获得美国纳税人的资金,其中提及的公司有华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国公司药明康德。美国与中国战略竞争众议院特别委员会主席迈克·加拉格尔(R-WI)和高级成员拉贾·克里希纳莫蒂(D-IL)今天提出了一项法案,以确保外国生物技术公司无法获得美国纳税人的资金。一旦颁布,该立法将限制联邦资助的医疗服务提供者使用外国对手生物技术公司,包括华大基因集团及其子公司华大智造和Complete Genomics,以及另一家中国-公司药明康德。罗姆尼参议员表示:“中国的生物技术公司正在通过医疗诊断测试收集世界各地数百万人的基因和敏感健康数据。”“我们的两党立法禁止与中国有联系的公司签订联邦合同和融资机制,这有助于确保美国纳税人的钱不被用来补贴威胁我们国家安全的生物技术公司。”“每天,美国人都会抽血或接受其他医学检查以保护他们的健康。但是,很少有人确切知道谁有权访问这些样本中包含的DNA信息,或者他们会如何使用这些信息。从DNA检测试剂盒到医疗诊断,随着生物技术领域在日常生活中变得越来越重要,外国对手控制的生物技术公司构成的威胁持续增长。”“这项法案将保护美国人的个人健康和遗传信息免受外国对手的侵害,这些对手有能力和动机利用这些信息来破坏我们的国家安全。”不过,这份提案是否最终能够通过,还有待观察。此前,涉外的医药公司亦遭遇过多次黑天鹅事件,但随后均一一化解。这次,是否能够避免冲击,或许还需要有关方面更进一步的解释。针对美国个别议员拟相关生物安全法提案提议禁止华大基因、药明康德等外国生物公司一事,以及文件中提及“药明生物首席执行官陈智胜曾任中国人民解放军军事医学科学院兼职教授”这一信息,1月26日下午,药明生物首席执行官陈智胜在回应界面新闻记者时称,“这只是一个反华议员的提议,到变成法律是极小概率事件,而且要几年时间。我个人也没有在军方任何机构任职过。我们会尽快公告澄清一下。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":984,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":18,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":267228451115120,"gmtCreate":1706250801461,"gmtModify":1706250908251,"authorId":4109218636328710,"author":{"id":4109218636328710,"authorId":4109218636328710,"name":"LukeMaya","avatar":"https://static.tigerbbs.com/ac2eb9add3f2bda8fac7116b74684fdb","vip":1,"currentWearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.01","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"hat":"https://static.tigerbbs.com/e379cae6dff6a66d464cfdb7021903eb","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":267226112983112,"type":1,"supId":0,"prevId":0,"content":"[微笑] <t-t type=\"img\" src=\"https://static.tigerbbs.com/765c132faa72f3e8c38827009c98cfad\"></t-t>","text":"[微笑] <t-t type=\"img\" src=\"https://static.tigerbbs.com/765c132faa72f3e8c38827009c98cfad\"></t-t>","html":"[微笑] <t-t type=\"img\" src=\"https://static.tigerbbs.com/765c132faa72f3e8c38827009c98cfad\"></t-t>","likeSize":0,"commentSize":2,"subComments":[{"id":267230324039728,"gmtCreate":1706251316420,"gmtModify":1706251320110,"authorId":3566808741894846,"author":{"id":3566808741894846,"authorId":3566808741894846,"name":"hssssssl","avatar":"https://static.tigerbbs.com/292e62bc391ddf29d9637dac9cd1ada8","vip":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","exceedPercentage":"80.07%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":267226112983112,"type":1,"supId":267228451115120,"prevId":0,"content":"还是要有核心竞争力那 光搞 CXO没出路","text":"还是要有核心竞争力那 光搞 CXO没出路","html":"还是要有核心竞争力那 光搞 CXO没出路"},{"id":267229028356232,"gmtCreate":1706251087754,"gmtModify":1706251228913,"authorId":3566808741894846,"author":{"id":3566808741894846,"authorId":3566808741894846,"name":"hssssssl","avatar":"https://static.tigerbbs.com/292e62bc391ddf29d9637dac9cd1ada8","vip":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","exceedPercentage":"80.07%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":267226112983112,"type":1,"supId":267228451115120,"prevId":0,"content":"哎呦 老美又搞事情","text":"哎呦 老美又搞事情","html":"哎呦 老美又搞事情"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/267226112983112"}
精彩评论